SEATTLE, WA--(Marketwired - Apr 10, 2013) - The

New Post Public Reply Private Reply Replies (0) Message Board
testuser
SEATTLE, WA--(Marketwired - Apr 10, 2013) - The Polyclinic, one of the largest multi-specialty clinics in the Puget Sound region, has selected Phytel's Population Health Management solution and Verisk Health's Provider Intelligence solution to deliver a population health management platform that enables its more than 200 physicians to deliver higher-quality care at a lower cost. The Polyclinic is a pioneer in the healthcare industry's transition from a fee-for-service to a value-based payment model in which providers are paid according to the quality of care they deliver. The clinic has partnered both with commercial payers on such contracts and with the Centers for Medicare and Medicaid Services (CMS) as an early participant in the Medicare Shared Savings Program. The solutions from Phytel and Verisk Health will deliver a key platform that links financial and performance analytics with case management and population health tools within existing care delivery models. "Fundamental to becoming a value-based provider of healthcare services is the ability to collect, organize, and mine clinical data in a way that reliably allows evidenced-based care to be delivered in a patient-centered, timely, efficient, and cost-effective manner across a heterogeneous patient population," said Dr. Michael Tronolone, chief medical officer of The Polyclinic. "We see our implementation of the Phytel-Verisk platform as a big step toward achieving this capability." Phytel CEO Steve Schelhammer said, "The Polyclinic has committed to making value-based care a reality. We are confident our population health management tools, in combination with Verisk Health's solutions, will give The Polyclinic the range of insight it needs to improve system performance and quality of care while reducing costs across its entire patient population." Phytel's Population Health Management solution aggregates data from electronic health records and practice management systems in hundreds of physician groups nationwide and offers a suite of tools for automating population health management, including modalities for patient outreach, care gap identification, risk stratification, care management, patient engagement, transitions of care, and performance evaluation. Verisk Health's Provider Intelligence helps identify and target inappropriate use of medical resources, manage in-network and out-of-network costs and utilization, and drive physician and practice-level strategies focused on improving the patient experience and maintaining business stability and profitability. Combined, these services will deliver a key platform that links financial and performance analytics with case management and population health tools within existing care delivery models. The resulting solution will provide healthcare organizations the ability to identify and address high-cost or low-performing areas within their organization while engaging patients to improve the health of their entire population. "To succeed in the Shared Savings Program, we need fully developed and automated population health management capabilities that combine financial analytics, risk assessment, and quality improvement with care management tools," commented Denis McDonald, senior vice president of Business Services for The Polyclinic. "In Phytel and Verisk Health, we have found a solution that immediately furthers our strategy for meeting CMS requirements and realizing shared savings." Jim Bogdan, senior vice president of Provider Solutions at Verisk Health, said, "By combining the significant capabilities of these two companies, providers can implement quality-based initiatives that drive cost-effective care delivery and improve system performance. These data-driven initiatives are a critical step toward improving a population's well-being and reducing costs associated with gaps in care, uncoordinated service delivery, and unnecessary utilization." About The Polyclinic The Polyclinic is made up of nearly 200 physicians, including internal medicine, family medicine, OB/gyn, pediatrics, and 24 additional medical and surgical specialties at ten locations in and around Seattle. Since its inception in 1917, The Polyclinic's mission has been to promote the health of its patients through high-quality, comprehensive, and personalized care. For more information, visit www.polyclinic.com. About Phytel The premier company empowering physician-led population health improvement, Phytel provides physicians with proven technology to deliver timely, coordinated care to their patients. Phytel's state-of-the-art registry, which now encompasses more than 30 million patients nationwide, uses evidence-based chronic and preventive care protocols to identify and notify patients due for service, while tracking compliance and measuring quality and financial results. For more information, please visit www.phytel.com. Follow us on Twitter and find us on Facebook. About Verisk Health Verisk Health drives performance excellence in the business of healthcare. By combining clinical and analytics expertise with robust technology and services, we empower customers to fully leverage their data to achieve long-term measurable results. Our data-driven risk assessment technologies and business decision analytics enable clients to proactively seize opportunities for improving clinical, financial, and performance results, including care management; risk identification and stratification; HEDIS compliance; benefit program measurement; fraud, waste, and abuse prevention; payment accuracy; and revenue cycle management. Verisk Health is a subsidiary of Verisk Analytics (NASDAQ: VRSK). For more information, visit www.veriskhealth.com. Contacts: Todd Stein Phytel 916-346-4213 Email Contact Trish Tarantino Verisk Health 781-693-3784Email Contact

View More
Investors-Hangout-Stock-Message-Boards-thumbnail-2015.png

test123 kjk
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

iCapital Enhances Portfolio Solutions For Global Investors

Updated Category News Views 267

iCapital Enhances Portfolio Construction Tools for Investors iCapital, a leading global fintech platform, has introduced significant enhancements to its innovative portfolio construction tool, iCapital Architect. This advanced platform is designed to simplify the integration of alternative investments into traditional portfolio strategies. Financial advisors gain access...

Continue Reading
Market Adaptability: S&P 500 Faces Correction Ahead

Updated Category News Views 210

Understanding Recent Market Movements The market experienced a turbulent session recently, sending investors into a state of caution. This volatility was significantly influenced by renewed discussions around tariffs impacting trade relationships, particularly involving technology and manufacturing sectors. The Impact of Tariffs on the Market Former President Trump's...

Continue Reading
Performance Systems Integration Merges with Summit Fire & Security

Updated Category News Views 177

Performance Systems Integration Merger with Summit Fire & Security Performance Systems Integration (PSI), recognized as the leading fire and life safety solutions provider in the Pacific Northwest, has completed a merger with Summit Fire & Security LLC, which is a subsidiary of SFP Holding, Inc. This merger marks a significant collaboration that aims to enhance the safety...

Continue Reading
Candel Therapeutics Shares Optimistic Findings on CAN-3110

Updated Category News Views 159

Revealing Interim Results from Candel Therapeutics NEEDHAM, Mass. — Candel Therapeutics, Inc. (Nasdaq: CADL), a biopharmaceutical company dedicated to advancing biological immunotherapies to combat cancer, has announced noteworthy interim data stemming from its ongoing phase 1b clinical trial of CAN-3110 (linoserpaturev) targeting recurrent glioblastoma. This...

Continue Reading
Supernus Pharmaceuticals Reaches New Heights with Strong Growth

Updated Category News Views 83

Supernus Pharmaceuticals Hits Record Stock Levels Supernus Pharmaceuticals Inc (NASDAQ: SUPN) has achieved a remarkable milestone, as its stock recently surged to a 52-week high of $35.45. This significant increase showcases the company’s strong financial performance and growth prospects, creating a wave of optimism among investors. The stock has risen an impressive...

Continue Reading